Wockhardt Ltd.

In News

Wockhardt Ltd Reports Positive Quarterly Performance Amid Shifting Financial Trends - Markets Mojo

Markets Mojo - Feb 11, 2026

Wockhardt Ltd dumps US generic pharma segment after losses, bets on antibiotics and insulin - The Economic Times

The Economic Times - Jul 11, 2025

Wockhardt shares gain 3% after positive Q3 results across parameters - CNBC TV18

CNBC TV18 - Feb 10, 2026

Wockhardt Shares Jump More Than 11% After Landmark Acceptance — Here's What You Need To Know - NDTV Profit

NDTV Profit - Dec 02, 2025

Wockhardt's New Drug Application for Antibiotic Accepted by US FDA; Shares Jump 18% - marketscreener.com

marketscreener.com - Dec 01, 2025

Wockhardt Q3 Profit Surge Masks Debt, Regulatory Shadows - Whalesbook

Whalesbook - Feb 10, 2026

Wockhardt New Drug Application for Breakthrough antibiotic Zaynich accepted by USFDA - Medical Dialogues

Medical Dialogues - Dec 01, 2025

Wockhardt shares jump 20% as US FDA accepts firm's new drug application for antibiotic Zaynich - Moneycontrol

Moneycontrol - Dec 01, 2025

Wockhardt to exit US generic pharma segment, shut down 2 subsidiaries - The Indian Express

The Indian Express - Jul 11, 2025

Wockhardt Limited's (NSE:WOCKPHARMA) Price Is Out Of Tune With Revenues - simplywall.st

simplywall.st - Nov 10, 2025

Wockhardt Ltd Exits US Generics Business, Focuses on Antibiotics and Biologics - scanx.trade

scanx.trade - Jul 13, 2025

Wockhardt Ltd Technical Momentum Shifts Amid Mixed Market Signals - Markets Mojo

Markets Mojo - Feb 12, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment